The Charcot-Marie-Tooth disease market comprises drugs used for treatment of Charcot-Marie-Tooth disease, which is characterized by progressive degeneration of peripheral nerves leading to loss of muscle tissue and touch sensation. Drugs widely used for treatment include prednisone, corticosteroids, tricyclic antidepressants, and dorsal column stimulators. The Global Charcot-Marie-Tooth Disease...